BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/30/2016 5:41:00 PM | Browse: 1246 | Download: 2045
Publication Name World Journal of Clinical Oncology
Manuscript ID 21677
Country United States
ISSN 2218-4333 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Review
Article Title Advanced oropharyngeal squamous cell carcinoma: Pathogenesis, treatment, and novel therapeutic approaches
Manuscript Source Invited Manuscript
All Author List Paul L Swiecicki, Kelly M Malloy and Francis P Worden
Funding Agency and Grant Number
Corresponding Author Swiecicki, MD, Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan Comprehensive Cancer Center, 1500 E. Medical Center Drive, SPC 5848, Ann Arbor, MI 48109, United States. pswiecic@med.umich.edu
Key Words Oropharyngeal cancer; Human papilloma virus; Transoral robotic surgery; Immunotherapy; Metastatic head and neck squamous cell carcinoma
Core Tip Treatment of oropharyngeal cancer entails a multi-disciplinary approach with concomitant chemoradiation. Given advances in the understanding of human papilloma virus related oropharyngeal cancer, ongoing research is looking at ways to minimize toxicities via de-intensification of therapy. Unfortunately, some patients develop recurrent or metastatic disease. This review discusses the current understanding of the pathogenesis of oropharyngeal cancer and treatment. We also discuss emerging areas of research as it pertains to de-intensification as well novel therapeutics for the management of metastatic disease.
Publish Date 2016-01-30 17:42
Citation Swiecicki PL, Malloy KM, Worden FP. Advanced oropharyngeal squamous cell carcinoma: Pathogenesis, treatment, and novel therapeutic approaches. World J Clin Oncol 2016; 7(1): 15-26
URL http://www.wjgnet.com/2218-4333/full/v7/i1/15.htm
DOI http://dx.doi.org/10.5306/wjco.v7.i1.15
Full Article (PDF) WJCO-7-15.pdf
Full Article (Word) WJCO-7-15.doc